IPO & secondary preview: Week of Feb. 26, 2007

Posted Feb 26th 2007 3:15PM by Joseph Lazzaro
Filed under: SEC Filings, Other Issues, Competitive Strategy

Wall Street's equity market continues in light-schedule mode this week, with just 2 IPOs and 2 Secondaries on the docket.

Those deals tentatively scheduled to price include:

IPOs:

Tuesday

Churchill Ventures (CHV), a 12.5 million-share IPO for this special purposes corporation. The Bank of America is the lead manager. Filing price: $8.

OncoGenex Technologies (OGXI), a 4.5 million-share IPO for this anti-cancer medicine company. RCB Capital Markets is the lead manager. Filing range: $10-$12.

Secondaries:

Tuesday

Rosetta Genomics (ROSG), a 3.75 million-share Secondary for this gene-based medical company. CE Unterberg is the lead manager.

Friday

Mylan Laboratories (MYL), a 21.5 million-share Secondary for this pharmaceutical company. Merrill Lynch and JP Morgan Chase are the lead managers.

For the latest market intelligence on IPOs, Syndicate, and after-market trades, check out TheFLY Syndicate at www.theflyonthewall.com. (Subscription required.)

Tags: MylanLaboratories